These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19890252)

  • 1. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.
    Olvey EL; Clauschee S; Malone DC
    Clin Pharmacol Ther; 2010 Jan; 87(1):48-51. PubMed ID: 19890252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of four drug interaction compendia.
    Vitry AI
    Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug information resources in the Veterans Affairs healthcare system.
    Haynes LM; Patterson AA; Wade SU
    Hosp Pharm; 1995 Apr; 30(4):297-301. PubMed ID: 10141871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
    Chan A; Tan SH; Wong CM; Yap KY; Ko Y
    Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance of severity ratings provided in four drug interaction compendia.
    Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug information service for drug product procurement in the Veterans Affairs health-care system: preliminary experience.
    Haynes LM; Patterson AA; Wade SU
    Am J Hosp Pharm; 1992 Mar; 49(3):595-8. PubMed ID: 1598933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interaction microcomputer software evaluation: PDR's drug interactions and side effects diskettes.
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 Sep; 25(9):839-42, 851. PubMed ID: 10170593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quality of pharmacotherapy in older veterans discharged from the emergency department or urgent care clinic.
    Hastings SN; Sloane RJ; Goldberg KC; Oddone EZ; Schmader KE
    J Am Geriatr Soc; 2007 Sep; 55(9):1339-48. PubMed ID: 17767675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important aspects of end-of-life care among veterans: implications for measurement and quality improvement.
    Casarett D; Pickard A; Amos Bailey F; Ritchie C; Furman C; Rosenfeld K; Shreve S; Shea JA
    J Pain Symptom Manage; 2008 Feb; 35(2):115-25. PubMed ID: 18053680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiropractic consultation requests in the Veterans Affairs Health Care System: demographic characteristics of the initial 100 patients at the Western New York medical center.
    Dunn AS; Towle JJ; McBrearty P; Fleeson SM
    J Manipulative Physiol Ther; 2006; 29(6):448-54. PubMed ID: 16904490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for estimating and comparing VA outpatient drug benefits with the private sector.
    Render ML; Nowak J; Hammond EK; Roselle G
    Med Care; 2003 Jun; 41(6 Suppl):II61-9. PubMed ID: 12773828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment guidelines, national formulary take shape in VA system.
    Am J Health Syst Pharm; 1996 Dec; 53(24):2950. PubMed ID: 8974157
    [No Abstract]   [Full Text] [Related]  

  • 16. The future of Veterans Affairs Medical Centers.
    Smith CB
    West J Med; 1997 Dec; 167(6):420-5. PubMed ID: 9426482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The whole is greater than the sum of its parts: the anatomy of the Department of Veterans Affairs Medical District 17 Health Services Research and Development Field Program.
    Demakis JG; Turpin RS; Conrad KJ; Stiers WM; Weaver FM; Sinacore JM; Cowper DC; Darcy LA; Huck MN; Friedman BS
    Health Serv Res; 1990 Apr; 25(1 Pt 2):269-85. PubMed ID: 2184151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 19. Access to kidney transplantation among patients insured by the United States Department of Veterans Affairs.
    Gill JS; Hussain S; Rose C; Hariharan S; Tonelli M
    J Am Soc Nephrol; 2007 Sep; 18(9):2592-9. PubMed ID: 17687075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
    Wang LM; Wong M; Lightwood JM; Cheng CM
    Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.